<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF)-α inhibitors (anti-TNF-α biologic drugs), currently used to treat different autoimmune conditions, may be associated with cutaneous drug reactions </plain></SENT>
<SENT sid="1" pm="."><plain>New <z:hpo ids='HP_0003674'>onset</z:hpo> or worsening of <z:hpo ids='HP_0003765'>psoriasis</z:hpo> and <z:hpo ids='HP_0003765'>psoriasis</z:hpo>-like reactions have been reported in these patients </plain></SENT>
<SENT sid="2" pm="."><plain>However, not much is known about the different histopathologic patterns of such <z:mp ids='MP_0001212'>skin lesions</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of this study was to evaluate the pathologic spectrum of clinically papulosquamous to pustular "psoriasiform" lesions in this setting </plain></SENT>
<SENT sid="4" pm="."><plain>Sixteen biopsies from 9 patients on anti-TNF-α therapy for <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> (n = 7), <z:e sem="disease" ids="C0010346" disease_type="Disease or Syndrome" abbrv="">Crohn disease</z:e> (n = 1), and <z:chebi fb="6" ids="22696">Beh</z:chebi>çet disease (n = 1) who developed a "psoriasiform" <z:hpo ids='HP_0000988'>skin rash</z:hpo> during treatment were included in this study </plain></SENT>
<SENT sid="5" pm="."><plain>None of the patients had history of <z:hpo ids='HP_0003765'>psoriasis</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Five patients (10 biopsies) showed a <z:hpo ids='HP_0003765'>psoriasis</z:hpo>-like pattern that varied from that seen in guttate lesions (4 biopsies), to well-established plaques (3 biopsies) to pustular <z:hpo ids='HP_0003765'>psoriasis</z:hpo> (3 biopsies) </plain></SENT>
<SENT sid="7" pm="."><plain>Three patients (4 biopsies) showed an interface/lichenoid <z:hpo ids='HP_0000964'>dermatitis</z:hpo> mimicking <z:e sem="disease" ids="C0023646" disease_type="Disease or Syndrome" abbrv="">lichen planus</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Two patients (2 biopsies) showed features of pustular <z:mp ids='MP_0000376'>folliculitis</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>Eosinophils varied from none (2 biopsies) to scattered (7 biopsies) to numerous (7 biopsies) </plain></SENT>
<SENT sid="10" pm="."><plain>Plasma cells were present in most cases </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> pustular lesions had negative cultures </plain></SENT>
<SENT sid="12" pm="."><plain>In conclusion, anti-TNF drugs elicit a spectrum of cutaneous reactions that go beyond the classical eosinophilic-rich hypersensitivity reaction and may closely mimic primary <z:hpo ids='HP_0000964'>dermatitis</z:hpo> </plain></SENT>
<SENT sid="13" pm="."><plain>In addition to <z:hpo ids='HP_0003765'>psoriasis</z:hpo>-like lesions, <z:e sem="disease" ids="C0023646" disease_type="Disease or Syndrome" abbrv="">lichen planus</z:e>-like <z:hpo ids='HP_0000964'>dermatitis</z:hpo> and <z:mp ids='MP_0001924'>sterile</z:mp> pustular <z:mp ids='MP_0000376'>folliculitis</z:mp> should be included in the list of anti-TNF-α-related drug reactions </plain></SENT>
<SENT sid="14" pm="."><plain>Because the different histopathologic findings may be subtle, clinical correlation is crucial to make the diagnosis </plain></SENT>
</text></document>